New Hepatitis C Drug Incivek Gets FDA Approval

The FDA has approved Incivek as an add-on to current interferon/ribavirn therapy for hepatitis C infection. Like Victrelis, also approved this month, Incivek greatly boosts the cure rate for hepatitis C.

Continued here:

New Hepatitis C Drug Incivek Gets FDA Approval

Posted by on May 23, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.